BDB018
BDB018-101
Phase 1 small_molecule completed
Quick answer
BDB018 for Tumor, Solid is a Phase 1 program (small_molecule) at Eikon Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eikon Therapeutics
- Indication
- Tumor, Solid
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed